BIO-Chardan Webinar: Evaluating Potential SPAC Partners

BIO-Chardan Webinar: Evaluating Potential SPAC Partners
October 21, 2021

More than 60 public Special Purpose Acquisition Companies (SPACs) are currently seeking life science companies for merger deals. Join this Biotechnology Innovation Organization (BIO) webinar to learn which financial, scientific, and managerial characteristics are most appealing to SPAC sponsors and the critical factors biotech management teams should prioritize in reviewing SPACs as potential fundraising sources. Learn from the following deal-making experts as they answer the moderator's and the audience's questions during the session.  

This session is part of BIO's "Anatomy of a SPAC Deal" Webinar Series, sponsored by Chardan.

Moderators & Speakers
Placeholder Image
Barbara Ryan, Moderator
Founder, Barbara Ryan Advisors; Editorial Advisory Board, Pharmaceutical Executive; Senior Advisor
Placeholder Image
Magdalene Cook
MD, President and Chief Executive Officer
Placeholder Image
Jonas Grossman
President and Managing Partner
Placeholder Image
Shannon Cheng
JD, Associate, Corporate Department, M&A Practice Group
Latham & Watkins LLP